Drugs Approved by the FDA

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Barr Laboratories
Approval Status: Approved March 1997
Treatment for: Anticoagulant, or "blood thinner" to keep blood clots from forming or getting larger

General Information

Seven strengths of Warfarin Sodium tablets, the generic equivalent of DuPont Merck’s anti-coagulant Coumadin, have been approved for marketing.